Ultragenyx Pharma (RARE) PT Raised to $96 at Cantor Fitzgerald

May 21, 2026 6:36 AM

Cantor Fitzgerald analyst Kristen Kluska raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $96.00 (from $84.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found